# VOLUME 2 · Business Architecture
_How BSGOTECH is organised as a business._

---

## 1. Corporate Structure
```
BSGOTECH GmbH — Technology Company (parent)
   │
   └── NeuNexus — Industrial Innovation Platform
          │
          ├── RENALIX — AI Healthcare
          └── NeuGreen Energy — Renewable Energy
```

BSGOTECH is the **parent technology company** — legal, IP and strategy hold. NeuNexus is the **integration platform** through which everything is delivered. RENALIX and NeuGreen Energy are the **operational divisions** — market-facing products, each with its own P&L and roadmap.

## 2. Brand Hierarchy
| Level | Brand | Role | Colour system |
|-------|-------|------|---------------|
| Parent | BSGOTECH | Technology infrastructure | Silver / white |
| Platform | NeuNexus | Integration and ecosystem | Green (`#22C55E`) |
| Division | RENALIX | AI healthcare | Rose (`#F43F5E`) |
| Division | NeuGreen Energy | Renewable energy | Teal (`#14B8A6`) |
| Vertical vision | NeuNexus Factory | Smart factory (proposed) | Amber (`#F59E0B`) |
| Vertical vision | NeuNexus Enterprise | Enterprise platform (roadmap) | Cyan (`#06B6D4`) |

Every logo appears with equal padding, equal height and equal typographical weight unless intentionally highlighted (parent > platform > division).

## 3. Platform Architecture
NeuNexus is the single operational spine. Every division consumes:
- **Shared data plane** — one European-hosted data lake with vertical partitions.
- **Shared AI core** — one model registry, one inference layer, vertical prompts.
- **Shared identity & access** — one JWT/OIDC scheme protecting internal areas.
- **Shared integration bus** — MQTT / OPC UA / FHIR / REST adapters.
- **Shared observability** — one telemetry backbone across all platforms.

## 4. Technology Architecture
```
Presentation:  React / Framer Motion / Tailwind
API layer:     FastAPI (Python) — /api/* only
Data plane:    MongoDB (documents, chunks, sessions), MinIO/Emergent object storage
Intelligence:  Gemini (chat), FastEmbed (embeddings), custom RAG
Auth:          bcrypt password + PyJWT bearer tokens
Deployment:    Emergent-managed preview + production (hx.bsgotech.com)
```

## 5. Value Chain
1. **Discovery** — market and partner scouting; opportunity qualification.
2. **Blueprint** — executive strategic report; RACI; consortium design.
3. **Integration** — NeuNexus platform assembly; data + AI + hardware pipelines.
4. **Deployment** — pilot with a lighthouse partner (hospital, factory, energy site).
5. **Operations** — SLAs, telemetry, KPI dashboards, iterative improvement.
6. **Scale** — regional expansion, standardisation, CKD/SKD manufacturing where applicable.

## 6. Revenue Model
- **License & platform fees** — NeuNexus platform access (SaaS-style, per site or per user).
- **Hardware & product sales** — NeuGreen Energy solar kits, storage, EMS.
- **Clinical intelligence subscriptions** — RENALIX Care / Pro per bed or per patient.
- **Integration and engineering services** — bespoke ecosystem assembly.
- **Research grants and public co-funding** — Horizon Europe, EU Innovation Fund, regional programmes.
- **Strategic partnerships and IP licensing** — technology transfer to industrial partners.

## 7. Growth Strategy
- **Anchor first, generalise second**: prove each platform with a lighthouse deployment before scaling.
- **Vertical, not horizontal**: focus on the four verticals we own — resist adjacencies until each vertical is mature.
- **Partner leverage**: use the ecosystem partners (Siemens, VCOW, DFOPTIX, NEURA, Fraunhofer, Bluesun, Wattzing, BENY) rather than reinventing.
- **Documentation as an asset**: every deployment produces a reusable blueprint, RACI and playbook.
- **Recurring revenue focus**: platform fees, subscriptions, service contracts > project revenue.

## 8. International Strategy
- **Phase 1 — DACH (2026-2027)**: Germany-first, extend into Austria and Switzerland; anchor NeuGreen Uetze and RENALIX pilots.
- **Phase 2 — Iberia (2027-2028)**: Portugal for pilot deployments and Portuguese-language markets; Spain for scale.
- **Phase 3 — Northern & Central Europe (2028-2030)**: Nordics, Benelux, Poland — energy and clinical use cases.
- **Phase 4 — Global adjacencies (2030+)**: North Africa (energy), Latin America (energy + health), only where a European partner already has presence.

Every phase is gated on:
1. Compliance readiness (regulator, language, data residency).
2. A signed local partner with skin in the game.
3. Positive unit economics at pilot scale.